<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7749772\results\search\disease\results.xml">
  <result pre="(THF-6) in comparison with oral diclofenac in patients with moderate-to-severe" exact="osteoarthritis" post="of the knee. Methods This randomized, double-blind, active-controlled, noninferiority"/>
  <result pre="This randomized, double-blind, active-controlled, noninferiority trial randomly assigned patients with" exact="osteoarthritis" post="of the knee to receive either THF-6 or diclofenac"/>
  <result pre="an alternative to oral diclofenac for the short-term treatment of" exact="osteoarthritis" post="of the knee. It was shown to be noninferior"/>
  <result pre="[4, 5]. Nearly half of the population may develop symptomatic" exact="osteoarthritis" post="of the knee by age 85, and the lifetime"/>
  <result pre="is doubled among obese individuals [6]. With increasing life expectancy," exact="osteoarthritis" post="of the knee is anticipated to cause even more"/>
  <result pre="medications for the management of knee pain in patients with" exact="osteoarthritis" post="of the knee [8]. The efficacy of oral NSAIDs,"/>
  <result pre="oral NSAIDs, diclofenac in particular, for symptomatic relief of knee" exact="osteoarthritis" post="has been well established in the literature [9]. Thanks"/>
  <result pre="initial oral medication of choice in the treatment of symptomatic" exact="osteoarthritis" post="of the knee with moderate-to-severe pain intensity [10, 11]."/>
  <result pre="[12, 13]. Given the large number of people affected with" exact="osteoarthritis" post="of the knee and societal trends in population aging"/>
  <result pre="of the knee and societal trends in population aging and" exact="obesity" post="[14], identifying effective and safe therapeutic options that are"/>
  <result pre="benefits in terms of pain and mobility in patients with" exact="osteoarthritis" post="of the knee [17â€&quot;19]. In Thailand, the Thai herbal"/>
  <result pre="the efficacy and tolerability of THF-6 in the treatment of" exact="osteoarthritis" post="of the knee [22], scientific proof of its benefits"/>
  <result pre="the standard drug, oral diclofenac, for the treatment of moderate-to-severe" exact="osteoarthritis" post="of the knee. 2. Methods 2.1. Trial Design and"/>
  <result pre="for the design, conduct, and reporting of clinical trials for" exact="osteoarthritis" post="of the knee [23]. It was prospectively registered with"/>
  <result pre="Eligible patients were 45 years of age or older with" exact="osteoarthritis" post="in one or both knees for more than three"/>
  <result pre="Patients were excluded if they also had any other underlying" exact="arthritis" post="(e.g., rheumatoid arthritis or gouty arthritis), signs or symptoms"/>
  <result pre="excluded if they also had any other underlying arthritis (e.g.," exact="rheumatoid arthritis" post="or gouty arthritis), signs or symptoms of active inflammation"/>
  <result pre="if they also had any other underlying arthritis (e.g., rheumatoid" exact="arthritis" post="or gouty arthritis), signs or symptoms of active inflammation"/>
  <result pre="the previous six weeks; had used symptomatic slow-acting drugs for" exact="osteoarthritis" post="(e.g., glucosamine sulfate or chondroitin sulfate) within the previous"/>
  <result pre="domain set for outcome measurement in clinical trials of knee" exact="osteoarthritis" post="[29, 30]. Outcome assessment was performed on a biweekly"/>
  <result pre="with higher scores indicating better improvement). In patients with bilateral" exact="osteoarthritis" post="of the knee, efficacy outcomes were assessed only for"/>
  <result pre="enrolled patients was 61.1â€‰Â±â€‰6.1â€‰years; 85.5% were women and 86% had" exact="osteoarthritis" post="in both knees. Baseline demographic and clinical characteristics of"/>
  <result pre="analgesic efficacy with acceptable safety profiles in patients with moderate-to-severe" exact="osteoarthritis" post="of the knee. In both the MITT and PP"/>
  <result pre="to consider THF-6 an alternative for the treatment of moderate-to-severe" exact="osteoarthritis" post="of the knee. The present clinical trial was designed"/>
  <result pre="THF-6 versus oral diclofenac for the short-term treatment of symptomatic" exact="osteoarthritis" post="of the knee. In clinical practice, pain relief medications,"/>
  <result pre="considered appropriate for determining the effects of THF-6 in symptomatic" exact="osteoarthritis" post="of the knee. With respect to osteoarthritic knee pain"/>
  <result pre="the beneficial effects of THF-6 in the treatment of symptomatic" exact="osteoarthritis" post="of the knee. Previous comprehensive literature reviews of C."/>
  <result pre="alternative to oral diclofenac for the short-term treatment of moderate-to-severe" exact="osteoarthritis" post="of the knee. Administration of THF-6 was shown to"/>
  <result pre="favored either THF-6 or oral diclofenac with respect to symptomatic" exact="osteoarthritis" post="of the knee. Acknowledgments The authors are grateful for"/>
  <result pre="8KingsburyS. R.HensorE. M.WalshC. A.HochbergM. C.ConaghanP. G.How do people with knee" exact="osteoarthritis" post="use osteoarthritis pain medications and does this change over"/>
  <result pre="M.WalshC. A.HochbergM. C.ConaghanP. G.How do people with knee osteoarthritis use" exact="osteoarthritis" post="pain medications and does this change over time? data"/>
  <result pre="medications and does this change over time? data from the" exact="osteoarthritis" post="InitiativeArthritis Research &amp;amp; Therapy2013155p. R10610.1186/ar428624008023 9da CostaB. R.ReichenbachS.KellerN.et al.Effectiveness"/>
  <result pre="American college of rheumatology/arthritis foundation guideline for the management of" exact="osteoarthritis" post="of the hand, hip, and kneeArthritis Care &amp;amp; Research202072214916210.1002/acr.2413131908149"/>
  <result pre="3 and 4 versus indomethacin solution in patients with symptomatic" exact="osteoarthritis" post="of the knee: a randomized controlled trialEvidence-Based Complementary and"/>
  <result pre="osteoarthritisCochrane Database Syst Rev201455 18ChenB.ZhanH.MarszalekJ.et al.Traditional Chinese medications for knee" exact="osteoarthritis" post="pain: a meta-analysis of randomized controlled trialsThe American Journal"/>
  <result pre="criteria for the classification and reporting of osteoarthritis: classification of" exact="osteoarthritis" post="of the kneeArthritis &amp;amp; Rheumatism19862981039104910.1002/art.17802908163741515 25BoonstraA. M.Schiphorst PreuperH. R.BalkG."/>
  <result pre="traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with" exact="osteoarthritis" post="or rheumatoid arthritis: a network meta-analysisArthritis Research &amp;amp; Therapy2015171p."/>
  <result pre="dataStatistics in Medicine200423121921198610.1002/sim.178315195324 29KingsburyS. R.CorpN.WattF. E.et al.Harmonising data collection from" exact="osteoarthritis" post="studies to enable stratification: recommendations on core data collection"/>
  <result pre="to enable stratification: recommendations on core data collection from an" exact="arthritis" post="research UK clinical studies groupRheumatology20165581394140210.1093/rheumatology/kew20127084310 30SmithT. O.HawkerG. A.HunterD. J.et"/>
  <result pre="documentation committee (IKDC) subjective knee evaluation form, knee injury and" exact="osteoarthritis" post="outcome score (KOOS), knee injury and osteoarthritis outcome score"/>
  <result pre="knee injury and osteoarthritis outcome score (KOOS), knee injury and" exact="osteoarthritis" post="outcome score physical function short form (KOOS-PS), knee ouArthritis"/>
  <result pre="34ChaipinyoK.Test-retest reliability and construct validity of Thai version of knee" exact="osteoarthritis" post="outcome score (KOOS)Thai Journal of Physical Therapy Science2009316776 35PhamT.van"/>
  <result pre="of Physical Therapy Science2009316776 35PhamT.van der HeijdeD.AltmanR. D.et al.OMERACT-OARSI Initiative:" exact="osteoarthritis" post="Research Society International set of responder criteria for osteoarthritis"/>
  <result pre="Initiative: osteoarthritis Research Society International set of responder criteria for" exact="osteoarthritis" post="clinical trials revisitedOsteoarthritis and Cartilage200412538939910.1016/j.joca.2004.02.00115094138 36CooperC.ChapurlatR.Al-DaghriN.et al.Safety of oral"/>
  <result pre="piperine in human interleukin 1Î²-stimulated fibroblast-like synoviocytes and in rat" exact="arthritis" post="modelsArthritis Research &amp;amp; Therapy2009112p. R4910.1186/ar2662 42MeghwalM.GoswamiT. K.Piper nigrum and"/>
  <result pre="sex (%) 87 84 BMI (kg/m2) 26.0â€‰Â±â€‰4.7 25.7â€‰Â±â€‰6.3a Location of" exact="osteoarthritis" post="(n) â€‰ â€‰ â€ƒRight knee 9 7 â€ƒLeft knee"/>
  <result pre="â€ƒGrade 3 68 73 â€ƒGrade 4 56 45 Duration of" exact="osteoarthritis" post="of the knee (years) 4.9â€‰Â±â€‰4.7 4.7â€‰Â±â€‰4.3 Underlying disease (n)"/>
  <result pre="systems â€‰ â€‰ â€‰ â€ƒPeripheral edema 4 5 1.000 â€ƒPeripheral" exact="neuropathy" post="2 1 1.000 â€ƒDizziness 1 2 1.000 â€ƒHeadache 1"/>
 </snippets>
</snippetsTree>
